0 التعليقات
0 المشاركات
655 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Advancing CAR-T Immunotherapy: The Growing Adoptive Cell Therapy MarketThe field of cancer immunotherapy has been revolutionized by the development of chimeric antigen receptor (CAR) T cell therapy, offering a personalized and highly effective treatment option for patients with hematologic malignancies. CAR-T immunotherapy involves engineering a patient's own T cells to recognize and attack cancer cells, providing a targeted approach with durable responses....0 التعليقات 0 المشاركات 730 مشاهدة 0 معاينة
-
Advancing Immunotherapy: How the CD52 Antibody Market is Transforming Treatment for Hematologic MalignanciesAdvancing Immunotherapy: How the CD52 Antibody Market is Transforming Treatment for Hematologic Malignancies The global biotechnology sector is witnessing a paradigm shift towards targeted immunotherapies that offer new hope for patients with challenging diseases. At the forefront of this revolution is the CD52 Antibody Market, a sector poised for significant growth as it addresses...0 التعليقات 0 المشاركات 485 مشاهدة 0 معاينة
-
Allergy Immunotherapy Market Growth, Demand, and Forecast Analysis 2034The allergy immunotherapy market is expanding as healthcare systems increasingly move beyond short-term symptom management toward therapies designed to modify allergic immune responses. Rising allergy prevalence, improved diagnostics, and advances in treatment formulations are creating new opportunities for long-term allergy management. The Allergy Immunotherapy Market was valued at US$ 2.47...0 التعليقات 0 المشاركات 426 مشاهدة 0 معاينة
-
Analyzing the CAR-T Cell Immunotherapy Market: Key Segments, Drivers, and Regional GrowthThe CAR-T cell immunotherapy market is shaped by a complex interplay of clinical success, technological innovation, and regional healthcare investment. The CAR-T cell immunotherapy market is on a powerful growth trajectory, projected to reach USD 29.14 billion by 2032. A detailed analysis of its segments and regional dynamics is essential for understanding its future direction. The...0 التعليقات 0 المشاركات 433 مشاهدة 0 معاينة
-
Bispecific Antibodies for Cancer Market – Dual-Targeting Immunotherapy Expanding Treatment OptionsMarket Overview Cancer immunotherapy continues to advance through molecules capable of engaging two distinct targets simultaneously. The Bispecific Antibodies For Cancer Market is growing as oncology developers pursue therapies that simultaneously bind tumor antigens and immune effector cells, enhancing the immune system's ability to target malignant cells directly. Hematology-oncology centers...0 التعليقات 0 المشاركات 486 مشاهدة 0 معاينة
-
Bladder Cancer Immunotherapy Market Set to Reach USD 29.75 Billion by 2036The global bladder cancer immunotherapy market is projected to reach USD 29.75 billion by 2036, rising from USD 11.44 billion in 2026 at a 10.0% CAGR, according to Fact.MR analysis. The market is expanding as immune checkpoint inhibitors gain broader use across first- and second-line treatment settings for advanced urothelial carcinoma. The forecast represents an absolute dollar opportunity of...0 التعليقات 0 المشاركات 496 مشاهدة 0 معاينة
-
Breast Cancer Immunotherapy Market – Precision Immune Approaches Reshaping Oncology CareMarket Overview The breast cancer immunotherapy market is expanding rapidly as checkpoint inhibitors, antibody-drug conjugates, and emerging cellular therapies move beyond triple-negative subtypes into broader clinical use. Oncologists increasingly incorporate immune-based approaches alongside chemotherapy and targeted agents, reflecting a shift toward personalized treatment strategies guided...0 التعليقات 0 المشاركات 573 مشاهدة 0 معاينة
-
Cancer Immunotherapy Market Future Opportunities in Targeted Cancer CareThe Cancer Immunotherapy Market is characterized by intense competition and a trend toward strategic alliances between key players. With intellectual property being a significant driver of value, companies are forming complex cross-licensing agreements to share technology and accelerate pipeline development. This cooperative competition is beneficial for the market as a whole, as it reduces...0 التعليقات 0 المشاركات 686 مشاهدة 0 معاينة
-
Cancer Immunotherapy Market Trends, Advancements in Cancer Treatment, Growth Opportunities, and Future Industry OutlookAccording to the latest report published by Data Bridge Market Research, the Cancer Immunotherapy Market The global cancer immunotherapy market size was valued at USD 95.69 billion in 2024 and is expected to reach USD 28.27 billion by 2032, at a CAGR of 15.50% during the forecast period This growth is driven by factors such as the increasing prevalence of cancer worldwide, advancements...0 التعليقات 0 المشاركات 824 مشاهدة 0 معاينة
-
CAR-T Cell Therapy Treatment Market Growth Driven by Rising Cancer Prevalence and Advanced ImmunotherapyAccording to the latest report published by Data Bridge Market Research, the CAR-T Cell Therapy treatment Market CAGR Value The global CAR-T Cell Therapy Treatment market size was valued at USD 10.89 billion in 2024 and is expected to reach USD 102.21 billion by 2032, at a CAGR of 32.30% during the forecast period This CAR-T Cell Therapy...0 التعليقات 0 المشاركات 991 مشاهدة 0 معاينة
-
Cell-Based Immunotherapy Market: Advancing Personalized Immunotherapy SolutionsThe global cell-based immunotherapy market is expanding as advances in cellular engineering and immuno-oncology broaden the applications of immune-cell-based treatments. CAR-T, TCR-T, CAR-NK, and tumor-infiltrating lymphocyte therapies are being developed for a growing range of cancer indications. Increasing clinical research, development of off-the-shelf allogeneic therapies, advances in gene...0 التعليقات 0 المشاركات 378 مشاهدة 0 معاينة
-
Acquired Hemophilia Treatment Market Growth Fueled by Rising Bleeding Disorder CasesThe global healthcare industry is increasingly focusing on rare disease management and advanced hematology treatments, creating strong growth opportunities for the acquired hemophilia treatment market. Acquired hemophilia is a rare autoimmune bleeding disorder caused by the development of autoantibodies against clotting factors, particularly factor VIII. The condition can lead to severe...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Antibodies Market Expands as Pharmaceutical R&D Investment RisesThe Antibodies Market is projected to grow from USD 256.1 billion in 2026 to USD 489.8 billion by 2036 at a 6.7% CAGR. ROCKVILLE, MD — October 6, 2026 — The Antibodies Market is projected to reach USD 489.8 billion by 2036, rising from USD 256.1 billion in 2026 at a CAGR of 6.7%, according to Fact.MR. The market was valued at approximately USD 240.0 billion in 2025 and is expected...0 التعليقات 0 المشاركات 757 مشاهدة 0 معاينة
-
Cytokine Market Insights and Strategic Industry AnalysisThe growing focus on immunology, targeted therapies, and advanced biologics is significantly driving the expansion of the cytokine industry worldwide. Cytokines play a vital role in regulating immune responses, inflammation, and cell signaling, making them essential in the treatment of cancer, autoimmune disorders, infectious diseases, and inflammatory conditions. Increasing investments in...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
GVHD Treatment Market Projected to Reach US$ 4.60 Billion by 2033The Gvhd Treatment Market is covered by Business Market Insights with 2025 as the base year and 2026–2033 as the forecast period. The retrieved public source material for this batch did not expose all three headline values required for a verified numerical opening, so no market-size figure or CAGR is inferred. Market growth is best understood as the interaction between customer demand,...0 التعليقات 0 المشاركات 95 مشاهدة 0 معاينة
-
Immunotherapy Drugs Market Growth and the Search for More Targeted TreatmentsA growing disease burden is changing the economics and direction of modern drug development. As cancer and chronic immune-related conditions become more widespread, healthcare systems are looking for therapies that can deliver more targeted responses. This shift is creating a powerful growth environment for the Immunotherapy Drugs Market, which reached USD 285.7 billion in 2025 and is expected...0 التعليقات 0 المشاركات 545 مشاهدة 0 معاينة
-
Intravesical Bacillus Calmette Market Growth Supported by Healthcare AdvancementsThe global intravesical Bacillus Calmette market is experiencing significant growth due to the increasing prevalence of bladder cancer and the rising adoption of immunotherapy-based treatment approaches. Intravesical Bacillus Calmette therapy has become one of the most widely used treatment options for non-muscle invasive bladder cancer (NMIBC), offering effective recurrence prevention and...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Lymphoma Treatment Market Growth Potential Driven by Advances in Cancer TherapeuticsThe lymphoma treatment market is witnessing significant growth as healthcare providers increasingly focus on improving outcomes for patients diagnosed with Hodgkin lymphoma and non-Hodgkin lymphoma. Rising cancer prevalence, advancements in oncology research, and the growing adoption of innovative treatment approaches are contributing to the expansion of the market. The development of targeted...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Primary Mediastinal Large B-cell Lymphoma Treatment Market: Global Analysis, Oncology Trends and Future OutlookAccording to the latest report published by Data Bridge Market Research, the Primary Mediastinal Large B-cell Lymphoma Treatment Market CAGR Value The global primary mediastinal large B-cell lymphoma treatment market size was valued at USD 850.00 million in 2025 and is expected to reach USD 1,354.77 million by 2033, at a CAGR of 6.00% during the...0 التعليقات 0 المشاركات 433 مشاهدة 0 معاينة
-
Regional Growth Prospects for the Ovarian Cancer Drugs MarketThe Ovarian Cancer Drugs Market is evolving as the need for effective cancer treatments increases worldwide. Valued at USD 3.4 billion in 2022, the Ovarian Cancer Drugs Market is projected to reach USD 5.7 billion by 2030, expanding at a CAGR of 6.6% from 2023 to 2030. Growing ovarian cancer incidence, advances in targeted medicines, and the development of innovative therapies are supporting...0 التعليقات 0 المشاركات 830 مشاهدة 0 معاينة
الصفحات المعززة
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek